Invention Grant
US08455251B2 Method for isolating and culturing adult stem cells derived from human amniotic epithelium
有权
用于分离和培养源自人羊膜上皮的成体干细胞的方法
- Patent Title: Method for isolating and culturing adult stem cells derived from human amniotic epithelium
- Patent Title (中): 用于分离和培养源自人羊膜上皮的成体干细胞的方法
-
Application No.: US12668602Application Date: 2008-01-10
-
Publication No.: US08455251B2Publication Date: 2013-06-04
- Inventor: Jeong Chan Ra , Seob Il Shin , Sung Keun Kang , Sang Kyu Woo
- Applicant: Jeong Chan Ra , Seob Il Shin , Sung Keun Kang , Sang Kyu Woo
- Applicant Address: KR Seoul
- Assignee: RNL Bio Co., Ltd.
- Current Assignee: RNL Bio Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: Rabin & Berdo, P.C.
- Priority: KR10-2007-0114451 20071109
- International Application: PCT/KR2008/000172 WO 20080110
- International Announcement: WO2009/061024 WO 20090514
- Main IPC: C12N5/00
- IPC: C12N5/00

Abstract:
The present invention relates to a method for isolating and culturing adult stem cells derived from human amniotic membrane in high yield, and more particularly to a method for obtaining a large amount of adult stem cells, the method comprising obtaining amniotic epithelial cells from human amniotic tissue in high yield by treatment with dithiothreitol (DTT) and a low concentration of trypsin and culturing the amniotic epithelial cells in a medium containing a Rho-associated kinase inhibitor. The human amniotic epithelial cell-derived stem cells are easily extracted compared to existing therapeutic stem cells such as umbilical cord blood stem cells and bone marrow stem cells, the yield and proliferation thereof are significantly increased by DTT treatment, the addition of the ROCK inhibitor or the replacement of medium. Thus, the method can be used to efficiently prepare adult stem cells.
Public/Granted literature
- US20100266553A1 METHOD FOR ISOLATING AND CULTURING ADULT STEM CELLS DERIVED FROM HUMAN AMNIOTIC EPITHELIUM Public/Granted day:2010-10-21
Information query